Interestingly, in breast cancer cells the synthesis and release of CXCL12 is under the control of 17β-estradiol contributing to its proliferative effects and mediating, via a Src-dependent mechanism, EGFR transactivation [133, 154]. This evidence concerns the gene EGFR and breast carcinoma.